Kimberly Foster
About Kimberly Foster
Kimberly Foster is the Scientific Director at Bristol Myers Squibb in Princeton, New Jersey, with over 20 years of experience in the pharmaceutics and preformulation field.
Current Role at Bristol Myers Squibb
Kimberly Foster currently serves as the Scientific Director at Bristol Myers Squibb, located in Princeton, New Jersey. In her role, she oversees scientific research projects aimed at advancing pharmaceutical science and preclinical testing. She contributes her extensive experience in pharmaceutics and preformulation to guide the team toward successful drug discovery and development.
Previous Roles at Bristol Myers Squibb
Before becoming Scientific Director, Kimberly Foster held several notable positions at Bristol Myers Squibb. From 2019 to 2021, she was Senior Principal Scientist. From 2012 to 2019, she worked as Principal Scientist. Prior to that, she served as SR RES INVESTIGATOR II from 2010 to 2012. Across these roles, she was instrumental in leading multi-disciplinary teams and advancing new chemical entities (NCEs) from the lab to clinical trials.
Experience at Pfizer
Kimberly Foster's career includes significant tenure at Pfizer, where she was employed from 1998 to 2010. She began her journey as a Research Investigator and later ascended to Principal Scientist and then Senior Principal Scientist. During her time at Pfizer, she gained valuable experience in formulating poorly soluble compounds and leading Pharmaceutical Candidate Optimization teams.
Educational Background
Kimberly Foster earned her PhD in Pharmaceutical Chemistry from The University of Kansas, where she studied from 1993 to 1998. Her academic training laid a strong foundation for her specialization in preformulation and solid-state characterization of new chemical entities (NCEs).
Expertise and Specializations
With over 20 years of experience in pharmaceutics and preformulation, Kimberly Foster specializes in preformulation and solid-state characterization of new chemical entities (NCEs). She has expertise in designing formulation strategies to ensure in vivo exposure in preclinical studies and has led global, multi-disciplinary Pharmaceutical Science and Preclinical matrix teams. Additionally, Kimberly Foster is adept at advancing drug compounds to clinical testing and formulating poorly soluble compounds.